Purpose: The impact of hemodialysis (HD) on aortoiliac (AI) occlusive lesions remains unknown.Here, we report the 3-year clinical outcomes of endovascular treatment (EVT) for AI occlusive lesions in propensity-matched populations of patients who did and did not undergo HD.Methods: The cohort of this large-scale, multicenter, retrospective registry study included 574 consecutive patients with AI occlusive disease. Propensity score-matched analysis was performed to compare AI occlusive lesions between patients who did and did not undergo HD. The endpoints were primary patency, assisted primary patency, and secondary patency as well as overall survival and major adverse limb events (MALEs).Results: A total of 57 matched pairs of patients who did and did not undergo HD were analyzed after propensity score-matched analysis. No significant difference was observed in primary patency, assisted primary patency, secondary patency, and MALEs at 3 years. The survival rate was significantly lower in the HD group than in the without-HD group (68% vs. 93%, P = 0.03).Conclusions: Although the survival rate of HD patients was poor, the results of EVT for AI occlusive lesions were reasonable in these patients. K E Y W O R D S aortoiliac, hemodialysis, occlusive artery A recent study in 2015 declared that the choice of revascularization method should predominantly be based on the competence and experience of each vascular center, with the anatomic complexity, considering patient comorbidity and overall prognosis and supporting the concept of an endovascular-first approach in all four different types of lesions in highly experienced centers. 15Another recent study has shown that the results of a 5-year follow-up revealed no significant difference in primary patency between the Trans-Atlantic Inter-Society Consensus II (TASC II) D group and the other groups, although the success rate of the procedure was lower and complications were more frequent in the TASC D group. 16 Therefore, we focused on one of the most complex anatomies (occlusive lesions) and the impact of HD on the result after EVT for the AI artery. Here, we report the 3-year clinical outcomes of EVT for AI occlusive lesions with and without HD in propensity-matched populations.